Bokf Na lowered its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 17.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,439 shares of the conglomerate’s stock after selling 6,691 shares during the quarter. Bokf Na’s holdings in Danaher were worth $6,431,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Financial Life Planners bought a new stake in Danaher in the third quarter worth approximately $32,000. Magnetar Financial LLC boosted its holdings in shares of Danaher by 19.7% during the 3rd quarter. Magnetar Financial LLC now owns 4,118 shares of the conglomerate’s stock worth $816,000 after buying an additional 679 shares in the last quarter. Quadrant Capital Group LLC grew its position in shares of Danaher by 50.6% during the 3rd quarter. Quadrant Capital Group LLC now owns 19,401 shares of the conglomerate’s stock worth $3,847,000 after buying an additional 6,519 shares during the period. Van ECK Associates Corp increased its stake in shares of Danaher by 5.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,728,070 shares of the conglomerate’s stock valued at $342,607,000 after acquiring an additional 85,460 shares in the last quarter. Finally, Ceredex Value Advisors LLC increased its stake in shares of Danaher by 5.2% in the 3rd quarter. Ceredex Value Advisors LLC now owns 262,420 shares of the conglomerate’s stock valued at $52,027,000 after acquiring an additional 13,043 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Research Report on Danaher
Danaher Stock Performance
Shares of DHR stock opened at $186.39 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The firm has a fifty day simple moving average of $219.65 and a two-hundred day simple moving average of $215.49. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The firm has a market capitalization of $131.81 billion, a PE ratio of 36.98, a price-to-earnings-growth ratio of 2.63 and a beta of 0.93.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the firm earned $2.14 earnings per share. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. This is an increase from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 25.40%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
